Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer.

Maura ScarlatteiGiorgio BaldariMario SilvaStefano BolaAntonino SammartanoSilvia MigliariTiziano GrazianiCarla CiddaNicola SverzellatiLivia Ruffini

Published in: Tumori (2020)

Our findings suggest that PET/CT is a sensitive modality to hypothesize SARS-CoV-2 pneumonia in patients with cancer, even when asymptomatic. More data are needed to verify the correlation among immune response to SARS-CoV-2 infection, clinical evolution, and PET results. Under the strict safety measures implemented at the PET center, the number of potentially SARS-CoV-2-positive patients undergoing PET/CT was very low (1.6%), and no staff member has been diagnosed with infection as of April 30, 2020.

Keyphrases

pet ct
sars cov
respiratory syndrome coronavirus
patients undergoing
positron emission tomography
electronic health record
intensive care unit
respiratory failure
machine learning
acute respiratory distress syndrome
extracorporeal membrane oxygenation